Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer–Narrative ReviewReview Published on 2024-06-122024-09-05 Journal: International Journal of Molecular Sciences [Category] update2024, [키워드] CTLA-4 Gastric cancer Immune checkpoint inhibitors immune checkpoint molecules Immunotherapy PD-1 PD-L1 [DOI] 10.3390/ijms25126471 PMC 바로가기 [Article Type] Review
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapiesImmunology Review Published on 2024-04-262024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] alternative splicing Antibody therapy CTLA-4 HLA-G Immune checkpoints PD-1 PD-L1 [DOI] 10.3389/fimmu.2024.1386993 PMC 바로가기 [Article Type] Immunology Review
Plasmodium vivax infection alters the peripheral immunoregulatory network of CD4 T follicular cells and B cellsarticle Published on 2023-08-312024-09-01 Journal: Neurogastroenterology and motility : the official [Category] 말라리아, [키워드] CTLA-4 memory B cells Plasmodium vivax T follicular helper (Tfh) cells T follicular regulatory (Tfr) cells [Article Type] article
Association Between Serum Cytotoxic T Lymphocyte Antigen (CTLA)-4 Level and Disease Progression in Patients With Chronic Hepatitis BCross-Sectional Study Published on 2023-04-012024-09-05 Journal: Medical Archives [Category] update2024, [키워드] Chronic Hepatitis B CTLA-4 Hepatocellular carcinoma Liver cirrhosis [DOI] 10.5455/medarh.2023.77.142-145 PMC 바로가기 [Article Type] Cross-Sectional Study
Study of the Molecular Dynamics Stability in the Inhibitory Interaction of Tenofovir Disoproxil Fumarate against CTLA-4 in Chronic Hepatitis B PatientsOriginal Paper Published on 2023-01-012024-09-05 Journal: Medical Archives [Category] update2024, [키워드] CTLA-4 hepatitis B molecular docking nucleotide analogue tenofovir disoproxil fumarate [DOI] 10.5455/medarh.2023.77.227-230 PMC 바로가기 [Article Type] Original Paper
Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patientsArticle Published on 2022-09-232022-11-15 Journal: Medicine [Category] 바이오마커, 치료제, [키워드] addition analyzed Apoptosis apoptotic apoptotic cell association blood cell C-reactive protein can be used CD4+ cell CD8+ cell Cell cell count cells characterized Chest CT Clinical severity confirmed case correlated correlation COVID-19 COVID-19 case COVID-19 patient COVID-19 patients CRP CTLA-4 cytotoxic T-lymphocyte antigen-4 detect Diagnosis diagnostic Dyspnea eosinophil expressing expression ferritin flow cytometry healthy control healthy volunteer In-patients Increased Infectious disease lymphocyte Lymphocyte count lymphopenia neutrophil Patient patients Platelet proportion reduced severity significant difference significantly therapeutic targets Total up-regulated WBCs while white with COVID-19 [DOI] 10.1097/MD.0000000000030650 PMC 바로가기
The Role of Immune Regulatory Molecules in COVID-19Review Published on 2022-06-012023-07-08 Journal: Viral immunology [Category] COVID19(2023년), [키워드] BTLA COVID-19 CTLA-4 GITR PD-1 SARS-CoV-2 TIM-3 [DOI] 10.1089/vim.2021.0211 [Article Type] Review
The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19혈청 anti-SARS-CoV-2 IgA의 존재는 COVID-19로부터 1차 의료 종사자를 보호하는 것으로 보입니다Article Published on 2022-05-012022-09-12 Journal: European Journal of Immunology [Category] Coronavirus, COVID19(2023년), MERS, SARS, 진단, [키워드] allergy anti-SARS-CoV-2 Antibody Response appear BMI CD25 CD279 CD38 CD4+ T-cell CD69 cellular response Clinical data Contracting correlated COVID-19 CTLA-4 cytokine secretion cytotoxic Cytotoxic T cell expressing female granzyme B Health Health care worker humoral hypertension identify IFN-γ IgA IgA response IgG IgG response immune response individual Infection Male sex Neutralizing Neutralizing antibodies pandemic PCR-confirmed Primary Health Care proliferation PROTECT response SARS-CoV-2 SARS-CoV-2-specific T-cell response self-reported symptom serum serum IgG Sex smoking study population Swedish Symptoms T cell T-cell T-cell Response was used [DOI] 10.1002/eji.202149655 PMC 바로가기 [Article Type] Article
Diabetic ketoacidosis shortly after COVID-19 vaccination in a non-small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: A case reportPD-1과 CTLA-4 억제제를 병용 투여하는 비소세포폐암 환자에서 코로나19 예방접종 직후 당뇨병성 케톤산증: 1건 보고Case Reports Published on 2022-04-012022-09-11 Journal: Thoracic cancer [Category] COVID19(2023년), SARS, 바이오마커, [키워드] (PD-1 adverse event Case report Combination combination treatment COVID-19 COVID-19 vaccination CTLA-4 Diabetic diabetic ketoacidosis had no immune Immune checkpoint inhibitor immune-related adverse event. immunogenicity inhibitors lung cancer lymphocyte Patient PD-1 programmed cell death programmed cell death protein Protein receiving the SARS-CoV-2 vaccination [DOI] 10.1111/1759-7714.14352 PMC 바로가기 [Article Type] Case Reports
Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review articleReview article Published on 2022-04-012022-10-05 Journal: International immunopharmacology [Category] 비임상, [키워드] approach ART ART immunotherapy Cancer cancers CAR T cell therapy chronic infection CTLA-4 died disease HIV HIV infection HIV/AIDS Human immunodeficiency virus illness immunodeficiency Immunotherapy incidence morbidity Mortality oncology PD-1/PL-1 blockades people living with HIV PLWH Prevalence reduced significantly survival syndrome the epidemic the patient therapy Treatment United Nation with HIV [DOI] 10.1016/j.intimp.2022.108580 [Article Type] Review article